Age-stratified and sex-stratified incidence of central serous chorioretinopathy, 2011–2018
| Age group (yrs) | Average annual incidence | Incidence rate (95% CI) | ||||
| Man | Woman | Total | Man | Woman | Total | |
| 30–34 | 1333 | 394.8 | 1727.8 | 36.1 (35.4–36.8) | 11.1 (10.7 to 11.5) | 23.8 (23.4 to 24.4) |
| 35–39 | 3285.4 | 639.8 | 3925.1 | 76.5 (75.6–77.4) | 15.4 (15.0 to 15.8) | 46.5 (46.0 to 47.0) |
| 40–44 | 4513.5 | 919.9 | 5433.4 | 94.7 (93.7–95.7) | 19.9 (19.5 to 20.4) | 57.9 (57.4 to 58.4) |
| 45–49 | 3849 | 1010.6 | 4859.6 | 88.0 (87.0–88.9) | 23.6 (23.1 to 24.1) | 56.2 (55.6 to 56.7) |
| 50–54 | 2816.9 | 974.6 | 3791.5 | 71.8 (70.9–72.8) | 25.1 (24.6 to 25.7) | 48.6 (48.1 to 49.2) |
| 55–59 | 2124.5 | 855.1 | 2979.6 | 55.6 (54.7–56.4) | 22.2 (21.7 to 22.7) | 38.8 (38.3 to 39.3) |
| 60–64 | 1903.4 | 812.1 | 2715.5 | 43.5 (42.8–44.2) | 18.0 (17.5 to 18.4) | 30.5 (30.1 to 31.0) |
| 65–69 | 1509.5 | 696.1 | 2205.6 | 34.4 (33.8–35.0) | 14.8 (14.4 to 15.2) | 24.2 (23.9 to 24.6) |
| 70–74 | 1025.1 | 495.3 | 1520.4 | 28.8 (28.2–29.5) | 12.2 (11.8 to 12.6) | 19.9 (19.6 to 20.3) |
| 75–79 | 662 | 339.9 | 1001.9 | 23.3 (22.7–24.0) | 9.5 (9.2 to 9.9) | 15.6 (15.3 to 16.0) |
| 80–84 | 351.6 | 199.5 | 551.1 | 17.8 (17.1–18.4) | 6.8 (6.4 to 7.1) | 11.2 (10.8 to 11.5) |
| 85–89 | 130.4 | 89.1 | 219.5 | 12.6 (11.8–13.3) | 4.4 (4.0 to 4.7) | 7.1 (6.8 to 7.5) |
| 90 and above | 30.8 | 29.5 | 60.3 | 7.5 (6.6–8.5) | 2.2 (1.9 to 2.4) | 3.4 (3.1 to 3.7) |
| All participants | 23 535 | 7456.3 | 30 991.3 | 54.2 (53.9–54.4) | 15.7 (15.5 to 15.8) | 34.0 (33.9 to 34.2) |
The incidence rate is reported per 100 000 person-years.